US2022056530A1PendingUtilityA1

Method to predict the pattern of locomotion in horses

64
Assignee: ANDERSSON LISA SPriority: May 5, 2011Filed: Nov 10, 2021Published: Feb 24, 2022
Est. expiryMay 5, 2031(~4.8 yrs left)· nominal 20-yr term from priority
C12Q 1/6876A01K 29/00G01N 33/6875G01N 33/6872G01N 2333/4703C12Q 2600/156C12Q 2600/124C12Q 1/6883C12Q 1/6881
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods for predicting the pattern of locomotion in a horse including the ability of a horse to use different gaits and the ability to trot at a fast speed. The methods comprise determining in a sample of DNA obtained from a horse the presence or absence of at least one genetic marker, wherein said at least one genetic marker is located on horse chromosome 23, said marker being associated with the ability to use different gaits. The invention further provides primers that amplify markers being associated with the ability to use different gaits and hybridization probes to detect markers being associated with the ability to use different gaits and the ability to trot at a fast speed.

Claims

exact text as granted — not AI-modified
1 . A method for predicting the pattern of locomotion in a horse including the ability to use alternative gaits, to trot or pace at a fast speed, and to perform in dressage, said method comprising steps of;
 i) extracting DNA from a sample obtained from a horse, and   ii) determining in said DNA the presence or absence of the nonsense mutation in exon 2 of the DMRT3 gene at nucleotide position 22,999,655 on horse chromosome 23, said nucleotide position corresponding to nucleotide position 939 in SEQ ID NO:3, and position 51 in SEQ ID NO:23, wherein said determining comprises contacting a nucleotide primer that specifically binds to the DNA sequence between nucleotide positions 22,628,976 and 23,315,071 base pairs on horse chromosome 23 or to the complementary strand thereof with said extracted DNA under hybridizing conditions and detecting the presence of a hybridization product comprising the primer and said DNA,   
       wherein the nucleotide positions on horse chromosome 23 refer to the horse reference sequence according to the September 2007  Equus caballus  draft assembly EquCab2. 
     
     
         2 . The method according to  claim 1 , wherein said nucleotide primer specifically binds to the DNA sequence between nucleotide positions 22,919,878 and 23,011,289 base pairs on horse chromosome 23. 
     
     
         3 . The method according to  claim 1 , wherein said nucleotide primer specifically binds to the sequences SEQ ID NO:1, 3 and 5-25. 
     
     
         4 . The method according to  claim 1 , wherein said nucleotide primer is selected from SEQ NO:26, SEQ ID NO:27, SEQ ID NO:30, and SEQ ID NO:31. 
     
     
         5 . The use of the method according to  claim 1  for selection a horse for breeding. 
     
     
         6 . The use of the method according to  claim 1  for paternity testing. 
     
     
         7 . The method according to  claim 1 , wherein said nucleotide primer specifically binds to the DMRT3 gene. 
     
     
         8 . The method according to  claim 1 , wherein said determining is performed by polymerase chain reaction (PCR), allele specific hybridization, a 3′exonuclease assay, a Taqman assay, fluorescent dye and quenching agent-based PCR assay, allele-specific restriction enzymes (RFLP-based techniques), direct sequencing, the oligonucleotide ligation assay (OLA), pyrosequencing, the invader assay, minisequencing, DHPLC-based techniques, single strand conformational polymorphism (SSCP), allele-specific PCR, denaturating gradient gel electrophoresis (DGGE), temperature gradient gel electrophoresis (TGGE), chemical mismatch cleavage (CMG), heteroduplex analysis based system, techniques based on mass spectroscopy, invasive cleavage assay, polymorphism ratio sequencing (PRS), microarrays, a rolling circle extension assay, HPLC-based techniques, extension based assays, ARMS (Amplification Refractory Mutation System), ALEX (Amplification Refractory Mutation Linear Extension), SBCE (Single base chain extension), molecular beacon assays, invader assays, ligase chain reaction assays, 5′-nuclease assay-based techniques, hybridization capillary array electrophoresis (GAE), and solid phase hybridization, dot blots, reverse dot blots, and chips. 
     
     
         9 . The method according to  claim 1 , wherein said nucleotide primer specifically binds to the sequence SEQ ID NO: 18.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.